−0.349NOK
−302.12 MNOK
389.00 KNOK
2.37 B
About BERGENBIO ASA
Sector
CEO
Martin Olin
Headquarters
Bergen
Website
Employees (FY)
29
Founded
2007
ISIN
NO0010650013
FIGI
BBG00GF93S49
BerGenBio ASA engages in the development of biopharmaceutical product for cancer therapy. It focuses on developing a pipeline of AXL kinase inhibitors. Its lead product bemcentinib, is a selective and orally bio-available small molecule AXL inhibitor. The company was founded by James Bradley Lorens and David R. Micklem on December 21, 2007 and is headquartered in Bergen, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BGBIOO is 0.779 NOK — it has decreased by 7.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BERGENBIO ASA stocks are traded under the ticker BGBIOO.
BERGENBIO ASA is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
BGBIOO stock is 8.54% volatile and has beta coefficient of −1.52. Check out the list of the most volatile stocks — is BERGENBIO ASA there?
One year price forecast for BERGENBIO ASA has a max estimate of 2.000 NOK and a min estimate of 0.050 NOK.
BGBIOO earnings for the last quarter are −0.01 NOK whereas the estimation was −0.02 NOK which accounts for 50.00% surprise. Estimated earnings for the next quarter are −0.01 NOK. See more details about BERGENBIO ASA earnings.
BERGENBIO ASA revenue for the last quarter amounts to 0 NOK despite the estimated figure of 0 NOK. In the next quarter revenue is expected to reach 35.33 K NOK.
Yes, you can track BERGENBIO ASA financials in yearly and quarterly reports right on TradingView.
BGBIOO net income for the last quarter is −27.93 M NOK, while the quarter before that showed −48.84 M NOK of net income which accounts for 42.80% change. Track more BERGENBIO ASA financial stats to get the full picture.
Today BERGENBIO ASA has the market capitalization of 436.11 M, it has increased by 2.21% over the last week.
No, BGBIOO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BGBIOO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BERGENBIO ASA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 29.00 employees. See our rating of the largest employees — is BERGENBIO ASA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BERGENBIO ASA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BERGENBIO ASA stock shows the sell signal. See more of BERGENBIO ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BERGENBIO ASA future price: according to them, BGBIOO price has a max estimate of 2.00 NOK and a min estimate of 0.05 NOK. Read a more detailed BERGENBIO ASA forecast: see what analysts think of BERGENBIO ASA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BERGENBIO ASA EBITDA is −233.45 M NOK, and current EBITDA margin is −81.02 K%. See more stats in BERGENBIO ASA financial statements.